Trial intelligence / Profile preview

Desloratadine CAC study in SAR

NCT00311844Phase 4Completed

Sponsor
Organon & Co.
Start
Mar 2005
Primary completion
May 2005
Modality
Small Molecules
01

Overview

A Phase 4 trial of desloratadine in Seasonal Allergic Rhinoconjunctivitis (SAR), sponsored by Organon & Co.. Started Mar 2005; status: completed.

02

Drugs

desloratadine
03

Conditions

Seasonal Allergic Rhinoconjunctivitis (SAR)

Beyond the preview

Go deeper on NCT00311844.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00311844.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call